Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis
暂无分享，去创建一个
W. Kim | J. Dranoff | A. Lok | K. Reddy | P. Thuluvath | E. Verna | M. Russo | C. Bowlus | Helen T. Smith | D. Bernstein | L. Forman | M. Lucey | Lindsay Y King | E. Carey | C. Levy | M. McLaughlin | Sujit V. Janardhan | S. Rojter | Robert Brown | J. Hanje | H. Elbeshbeshy | A. Modi | J. Darling | R. Rubin | A. Goel | C. Landis | V. Clark | Marina G. Silveira | C. Stanca | M. Mayo | B. Borg | F. Rochling | W. Mark | R. Manch | H. Morris | L. Weiss | V. Ankoma‐Sey | A. Mospan | R. Jesudoss | Elizabeth Carey | Mitchell Shiffman | S. Harrison | C. Bowlus | G. Reddy | E. Mena | David Kim | A. Thompson | Robert Sandefur | Victor David Brian Christopher Robert Elizabeth Virginia Ankoma-Sey Bernstein Borg Bowlus Brown Car | V. Luketic | M. Silveira | Richard A. Manch
[1] G. Hirschfield. ENHANCE: Safety and Efficacy of Seladelpar in Patients With Primary Biliary Cholangitis-A Phase 3, International, Randomized, Placebo-Controlled Study. , 2021, Gastroenterology & hepatology.
[2] N. Mostafavi,et al. Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double blind, randomized, placebo-controlled trial. , 2020, Gastroenterology.
[3] K. Manfreda,et al. Web Versus Other Survey Modes: An Updated and Extended Meta-Analysis Comparing Response Rates , 2020, Journal of Survey Statistics and Methodology.
[4] J. Boyer,et al. Primary Biliary Cholangitis: 2018 Practice Guidance From the American Association for the Study of Liver Diseases , 2020, Clinical Liver Disease.
[5] G. Alexander,et al. Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[6] J. Boyer,et al. Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.
[7] V. de Lédinghen,et al. A Placebo‐Controlled Trial of Bezafibrate in Primary Biliary Cholangitis , 2018, The New England journal of medicine.
[8] G. Alexander,et al. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines , 2018, Gut.
[9] W. Kim,et al. A real‐world observational cohort of patients with primary biliary cholangitis: TARGET‐primary biliary cholangitis study design and rationale , 2018, Hepatology communications.
[10] G. Hirschfield,et al. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. , 2017, Journal of hepatology.
[11] J. Reguła,et al. A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. , 2016, The New England journal of medicine.
[12] David E. J. Jones,et al. A systematic approach to the management of cholestatic pruritus in primary biliary cirrhosis , 2015, Frontline Gastroenterology.
[13] P. Klein,et al. An evidence-based review of the efficacy of topical antihistamines in the relief of pruritus. , 2010, Journal of drugs in dermatology : JDD.
[14] L. Hynan,et al. The 5‐D itch scale: a new measure of pruritus , 2010, The British journal of dermatology.
[15] Katy Sutcliffe,et al. An integrated care pathway improves quality of life in Primary Biliary Cirrhosis. , 2008, QJM : monthly journal of the Association of Physicians.
[16] A. Jacoby,et al. Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis , 2005, Gut.
[17] A. Parés,et al. Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response , 2018, The American Journal of Gastroenterology.
[18] G. Hirschfield,et al. AUTOIMMUNE , CHOLESTATIC AND BILIARY DISEASE The Specificity of Fatigue in Primary Biliary Cirrhosis : Evaluation of a Large Clinic Practice , 2010 .